The 21 companies tracked in Exhibit 1 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017.
Numerous players affirmed or updated their own full-year revenue guidance at the 1Q mark. For example, Globus Medical increased its numbers based on adoption of ExcelsiusGPS, K2M grew its range by $3MM following a distributor partnership and Orthofix upped guidance by about $9MM in acquisition-related contributions. After the quarter’s close, Wright Medical announced FDA premarket approval for AUGMENT injectable bone graft, and will update its full-year guidance in the 2Q18 call.
Exhibit 1: Orthopaedic Sales for Public Companies, As-Reported: 1Q18 vs. 1Q17 ($MM)
Company
1Q18
1Q17
$ Chg
% Chg
Alphatec Spine
$21.3
$28.0
($6.7)
(23.9%)
Anika
$19.5
$20.2
($0.7)
(3.6%)
ConforMIS
$19.7
$20.5
($0.8)
(3.9%)
ConMed
$108.9
$103.8
$5.1
4.9%
DePuy Synthes
$2,250.0
$2,274.9
($24.9)
(1.1%)
DJO Surgical
$292.6
$288.3
$4.3
1.5%
Globus Medical
$174.4
$155.8
$18.6
11.9%
Integra
$24.8
$26.1
($1.2)
(4.8%)
K2M
$67.9
$61.9
$6.0
9.6%
Mazor Robotics
$15.5
$11.7
$3.8
32.5%
Medtronic
$787.0
$759.0
$28.0
3.7%
NuVasive
$260.5
$249.0
$11.6
4.6%
Orthofix
$108.7
$102.7
$6.0
5.8%
OrthoPediatrics
$12.1
$9.8
$2.3
23.9%
SeaSpine
$33.2
$31.9
$1.3
4.1%
Smith & Nephew
$865.4
$826.9
$38.5
4.7%
Stryker
$1,724.9
$1,612.3
$112.6
7%
Vericel
$12.1
$5.0
$7.1
142%
Wright Medical
$198.5
$177.2
$21.3
12%
Xtant Medical
$17.9
$22.1
($4.1)
(18.8%)
Zimmer Biomet
$1,856.6
$1,816.9
$39.7
2.2%
Sources: Company press releases, websites, the U.S. Securities and Exchange Commission
Julie A. Vetalice is the Editorial Assistant for ORTHOWORLD. Reach her via email.
The 21 companies tracked in Exhibit 1 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017.
Numerous players affirmed or updated their own full-year revenue guidance at the 1Q mark. For example, Globus Medical increased its numbers based on adoption of...
The 21 companies tracked in Exhibit 1 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017.
Numerous players affirmed or updated their own full-year revenue guidance at the 1Q mark. For example, Globus Medical increased its numbers based on adoption of ExcelsiusGPS, K2M grew its range by $3MM following a distributor partnership and Orthofix upped guidance by about $9MM in acquisition-related contributions. After the quarter’s close, Wright Medical announced FDA premarket approval for AUGMENT injectable bone graft, and will update its full-year guidance in the 2Q18 call.
Exhibit 1: Orthopaedic Sales for Public Companies, As-Reported: 1Q18 vs. 1Q17 ($MM)
Company
1Q18
1Q17
$ Chg
% Chg
Alphatec Spine
$21.3
$28.0
($6.7)
(23.9%)
Anika
$19.5
$20.2
($0.7)
(3.6%)
ConforMIS
$19.7
$20.5
($0.8)
(3.9%)
ConMed
$108.9
$103.8
$5.1
4.9%
DePuy Synthes
$2,250.0
$2,274.9
($24.9)
(1.1%)
DJO Surgical
$292.6
$288.3
$4.3
1.5%
Globus Medical
$174.4
$155.8
$18.6
11.9%
Integra
$24.8
$26.1
($1.2)
(4.8%)
K2M
$67.9
$61.9
$6.0
9.6%
Mazor Robotics
$15.5
$11.7
$3.8
32.5%
Medtronic
$787.0
$759.0
$28.0
3.7%
NuVasive
$260.5
$249.0
$11.6
4.6%
Orthofix
$108.7
$102.7
$6.0
5.8%
OrthoPediatrics
$12.1
$9.8
$2.3
23.9%
SeaSpine
$33.2
$31.9
$1.3
4.1%
Smith & Nephew
$865.4
$826.9
$38.5
4.7%
Stryker
$1,724.9
$1,612.3
$112.6
7%
Vericel
$12.1
$5.0
$7.1
142%
Wright Medical
$198.5
$177.2
$21.3
12%
Xtant Medical
$17.9
$22.1
($4.1)
(18.8%)
Zimmer Biomet
$1,856.6
$1,816.9
$39.7
2.2%
Sources: Company press releases, websites, the U.S. Securities and Exchange Commission
Julie A. Vetalice is the Editorial Assistant for ORTHOWORLD. Reach her via email.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
